Literature DB >> 9872405

Cardiac specific expression of the green fluorescent protein during early murine embryonic development.

M Fleischmann1, W Bloch, E Kolossov, C Andressen, M Müller, G Brem, J Hescheler, K Addicks, B K Fleischmann.   

Abstract

We demonstrate the establishment of transgenic mice, where the expression of the green fluorescent protein (GFP) is under control of the human cardiac alpha-actin promoter. These mice display cardiac specific GFP expression already during early embryonic development. Prominent GFP fluorescence was observed at the earliest stage of the murine heart anlage (E8). Cardiomyocytes of different developmental stages proved GFP positive, but the intensity varied between cells. We further show that contractions of single GFP positive cardiomyocytes can be monitored within the intact embryo. At later stages of embryonic development, the skeletal musculature was also GFP positive, in line with the known expression pattern of cardiac alpha-actin. The tissue specific labeling of organs is a powerful new tool for embryological as well as functional investigations in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872405     DOI: 10.1016/s0014-5793(98)01476-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  Functional expression and modulation of the L-type Ca2+ current in embryonic heart cells.

Authors:  Daniela Malan; Bernd K Fleischmann
Journal:  Pediatr Cardiol       Date:  2012-05-26       Impact factor: 1.655

2.  Microscopy and image analysis.

Authors:  George McNamara; Michael J Difilippantonio; Thomas Ried
Journal:  Curr Protoc Hum Genet       Date:  2005-08

3.  A 7.1 kbp beta-myosin heavy chain promoter, efficient for green fluorescent protein expression, probably induces lethality when overexpressing a mutated transforming growth factor-beta type II receptor in transgenic mice.

Authors:  Séverine Allegra; Lamia Bouazza; Claire Benetollo; Jacques Yuan Li; Dominique Langlois
Journal:  Transgenic Res       Date:  2005-02       Impact factor: 2.788

4.  Loss of annexin A7 leads to alterations in frequency-induced shortening of isolated murine cardiomyocytes.

Authors:  C Herr; N Smyth; S Ullrich; F Yun; P Sasse; J Hescheler; B Fleischmann; K Lasek; K Brixius; R H Schwinger; R Fässler; R Schröder; A A Noegel
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Differential subunit composition of the G protein-activated inward-rectifier potassium channel during cardiac development.

Authors:  Bernd K Fleischmann; Yaqi Duan; Yun Fan; Torsten Schoneberg; Andreas Ehlich; Nibedita Lenka; Serge Viatchenko-Karpinski; Lutz Pott; Juergen Hescheler; Bernd Fakler
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

6.  Targeting myofibroblasts in model systems of fibrosis by an artificial alpha-smooth muscle-actin promoter hybrid.

Authors:  Julia Hirschfeld; Julia Maurer; Diana Jung; Monika Kwiecinski; Al Karim Khimji; Hans Peter Dienes; Jochen W U Fries; Margarete Odenthal
Journal:  Mol Biotechnol       Date:  2009-06-24       Impact factor: 2.695

7.  Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene.

Authors:  K M Caron; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

8.  Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium.

Authors:  Eugen Kolossov; Toktam Bostani; Wilhelm Roell; Martin Breitbach; Frank Pillekamp; Jens M Nygren; Philipp Sasse; Olga Rubenchik; Jochen W U Fries; Daniela Wenzel; Caroline Geisen; Ying Xia; Zhongju Lu; Yaqi Duan; Ralf Kettenhofen; Stefan Jovinge; Wilhelm Bloch; Heribert Bohlen; Armin Welz; Juergen Hescheler; Sten Eirik Jacobsen; Bernd K Fleischmann
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

9.  Disruption of cytoskeletal integrity impairs Gi-mediated signaling due to displacement of Gi proteins.

Authors:  W Bloch; Y Fan; J Han; S Xue; T Schöneberg; G Ji; Z J Lu; M Walther; R Fässler; J Hescheler; K Addicks; B K Fleischmann
Journal:  J Cell Biol       Date:  2001-08-20       Impact factor: 10.539

10.  Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival.

Authors:  Leonie E Paulis; Alexandra M Klein; Alexander Ghanem; Tessa Geelen; Bram F Coolen; Martin Breitbach; Katrin Zimmermann; Klaas Nicolay; Bernd K Fleischmann; Wilhelm Roell; Gustav J Strijkers
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.